Durability of the Neutralizing Antibody Response to mRNA Booster Vaccination Against SARS-CoV-2 BA.2.12.1 and BA.4/5 Variants

The recent emergence of the SARS-CoV-2 BA.4/5 and BA.2.12.1 variants has led to rising COVID-19 case numbers and concerns over the continued efficacy of mRNA booster vaccination. Here we examine the durability of neutralizing antibody (nAb) responses against these SARS-CoV-2 Omicron subvariants in a...

Descripción completa

Detalles Bibliográficos
Autores principales: Qu, Panke, Faraone, Julia N., Evans, John P., Zheng, Yi-Min, Carlin, Claire, Lozanski, Gerard, Saif, Linda J., Oltz, Eugene M., Gumina, Richard J., Liu, Shan-Lu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327628/
https://www.ncbi.nlm.nih.gov/pubmed/35898337
http://dx.doi.org/10.1101/2022.07.21.501010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9327628/
https://www.ncbi.nlm.nih.gov/pubmed/35898337
http://dx.doi.org/10.1101/2022.07.21.501010

Ejemplares similares